Probiotic
VIROBIND-AB Capsule contains a unique combination of probiotics that is clinically approved to treat COVID-19 infections. VIROBIND-AB reduces the productions of IL-10, IL-12 and TNF- α, maintains gut health, enhances the intestinal mucosal barrier and modulates immunity
- Decreases the eosinophils, neutrophils & macrophage
- Enhances mucosal barrier function
- Faster recovery of the patients from COVID-19 symptoms
- Shown significant reduction of C-reactive protein, D-Dimer & Lung abnormalities
Added advantage of veg capsule
- Easy to Swallow
- Easy to Dissolve
COMPOSITION:
Each capsule contains 2BN CFU probiotic
MODE OF ACTION:
Strains L. plantarum CECT 7484, CECT 7485 and CNCM 5332 enhance mucosal barrier by producing molecules with:
- anti-permeability (polyphosphate granules)
- anti-inflammatory activity (acetate, Ach)
Strain L. plantarum CECT 30292 cross-talks through surface proteins to antigen presenting cells (DC’s and macrophages), which later interact with B lymphocytes, yielding to a boost of immune response to SARS-CoV-2
INDICATIONS
- Probiotic for the treatment of COVID-19 infections
Dosage
1 capsule per day
Disclaimer:
This information is for registered medical practitioner only. Anyone other than medical practitioner should consult medical practitioner before using this product.
Enquire About VIROBIND-AB
Fill the form below and we will get in touch with you